-
2025 Cambridge deals pass $9.25bn as AstraZeneca and Honeywell step on the gas
24 Oct 2025 23:36 GMT
… to scale transformative cancer treatments.
AstraZeneca, which recently pledged to invest … by CIC with participation from AstraZeneca and BioNTech.
Sortera has strategically … ), with support from AstraZeneca through the LMB-AstraZeneca Blue Sky Collaboration.
…
-
UK industry body finds AstraZeneca in breach of code over Symbicort marketing
24 Oct 2025 11:32 GMT
… By Carbonatix
(Reuters) -AstraZeneca breached the UK pharmaceutical industry … for anti-inflammatory reliever therapy.
AstraZeneca did not immediately respond to … symptom control or persistent exacerbations.
AstraZeneca argued that both treatment approaches …
-
AstraZeneca found in breach of industry code over Symbicort marketing, industry body says
24 Oct 2025 10:27 GMT
-
AstraZeneca found in breach of industry code over Symbicort marketing, industry body says
24 Oct 2025 09:45 GMT
(Reuters) -AstraZeneca breached the UK pharmaceutical industry’ …
-
AstraZeneca invests $445m in expanded Texas manufacturing facility
23 Oct 2025 19:01 GMT
… follows groundbreaking last week at AstraZeneca’s manufacturing facility in Albemarle … Vice President, Americas Supply Operations, AstraZeneca, said: “Our manufacturing facility in … across the country. In 2025, AstraZeneca created approximately $20 billion of …
-
Small Cell Lung Cancer Market Research 2025-2035, Competitive Analysis of Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Merck, Pfizer, PharmaMar, Sun Pharma, Teva - ResearchAndMarkets.com
23 Oct 2025 15:37 GMT
… -centric care.
Companies Featured
Amgen
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb …
-
Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership
23 Oct 2025 13:47 GMT
… market
Key Takeaways:
The AstraZeneca (NASDAQ:AZN) licensing deal … weight loss.
Supported by AstraZeneca, the drug is undergoing … 202 million yuan. When AstraZeneca became a strategic investor … entire revenue from the AstraZeneca collaboration, leading to a …
-
AstraZeneca-partnered Pinetree nears $47M Series B for protein degraders
23 Oct 2025 12:10 GMT
-
AstraZeneca Tezspire approved in EU for chronic rhinosinusitis with nasal polyps
23 Oct 2025 10:21 GMT
AstraZeneca and Amgen's Tezspire ( … and President, BioPharmaceuticals Business Unit, AstraZeneca, said, “In Europe, we know …
-
The NHL season is underway. AstraZeneca and Grey Health want fans to get body checked against cancer.
23 Oct 2025 09:01 GMT
… accomplish a three-peat.
Meanwhile, AstraZeneca has another goal in mind … of agency partner Grey Health, AstraZeneca is on an ongoing quest … in the pipeline to support AstraZeneca throughout the season.
And for …
About
© 1995-2025